Jacqueline B. Kosecoff net worth and biography

Jacqueline Kosecoff Biography and Net Worth

Director of STERIS

Dr. Jacqueline B. Kosecoff director since October 2003 and, since March 2012, Managing Partner, Moriah Partners, LLC, a private equity firm focused on health services and technology, and Senior Advisor to Warburg Pincus LLC, a private equity fund. She also has served as a member of the Executive Advisory Board of SAP America, Inc., a software and enterprise applications provider, from November 2010 through May 2017. From October 2007 to November 2011, Dr. Kosecoff served as Chief Executive Officer of OptumRx (formerly named Prescriptions Solutions), a pharmacy benefits management company and subsidiary of UnitedHealth Group, and continued to serve as a senior advisor to OptumRx from December 2011 to February 2012. Dr. Kosecoff served as Chief Executive Officer of Ovations Pharmacy Solutions, a UnitedHealth Group company, from December 2005 to October 2007. From July 2002 to December 2005, Dr. Kosecoff served as Executive Vice President, Specialty Companies, of PacifiCare Health Systems, Inc., one of the nation’s largest consumer health organizations. From 1998 to 2002, Dr. Kosecoff was President and Founder of Protocare, Inc., a firm involved in the development and testing of drugs, devices, biopharmaceutical and nutritional products, and consulting and analytic services. Dr. Kosecoff is a director of GoodRx Holdings, Houlihan Lokey, TriNet Group, Inc. and Alignment Healthcare. Dr. Kosecoff served as a director of athenahealth, Inc. until February 2019 and of Sealed Air Corporation until May 2021.

What is Jacqueline B. Kosecoff's net worth?: The estimated net worth of Jacqueline B. Kosecoff is at least $636,371.90 as of May 21st, 2021. Dr. Kosecoff owns 3,121 shares of STERIS stock worth more than $636,372 as of April 27th. This net worth evaluation does not reflect any other investments that Dr. Kosecoff may own. Learn More about Jacqueline B. Kosecoff's net worth.
How do I contact Jacqueline B. Kosecoff?: The corporate mailing address for Dr. Kosecoff and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Jacqueline B. Kosecoff's contact information.
Has Jacqueline B. Kosecoff been buying or selling shares of STERIS?: Jacqueline B. Kosecoff has not been actively trading shares of STERIS within the last three months. Most recently, Jacqueline B. Kosecoff sold 3,121 shares of the business's stock in a transaction on Friday, May 21st. The shares were sold at an average price of $192.59, for a transaction totalling $601,073.39. Following the completion of the sale, the director now directly owns 3,121 shares of the company's stock, valued at $601,073.39. Learn More on Jacqueline B. Kosecoff's trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 5/15/2023.

Jacqueline B. Kosecoff Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/21/2021	Sell	3,121	$192.59	$601,073.39	3,121
5/15/2019	Sell	3,609	$132.22	$477,181.98
2/28/2018	Sell	2,744	$91.94	$252,283.36

Jacqueline B. Kosecoff Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $203.90

$200.45

$204.64

50 Day Range

MA: $221.18

$198.94

$236.03

2 Week Range

Now: $203.90

$181.78

$254.00

Volume

318,142 shs

Average Volume

558,812 shs

Market Capitalization

$20.15 billion

P/E Ratio

35.71

Dividend Yield

1.03%

Beta

0.79

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy